Literature DB >> 8064482

Relationship of donor site to chondrogenic potential of periosteum in vitro.

S H Gallay1, Y Miura, C N Commisso, J S Fitzsimmons, S W O'Driscoll.   

Abstract

Periosteum has been shown in vitro and in vivo to have a chondrogenic potential that permits it to be used for cartilage regeneration. A useful donor site should have good chondrogenic potential, availability of a large quantity of periosteum, and relative ease of access, and it should be associated with a low rate of morbidity. We hypothesized that the chondrogenic potential of periosteum varies from one bone to another and among different regions of the periosteum from a single bone. A total of 370 periosteal and 37 fascia lata (control) explants were taken from the skull, the ilium, the scapula, the upper, middle, and lower medial proximal tibia, the posterior proximal tibia, and the distal tibia of 2-month-old New Zealand rabbits. The explants were cultured for 6 weeks in agarose/Dulbecco's modified Eagle medium to which 10 ng/ml of transforming growth factor-beta 1 was added during the first 2 weeks. Skeletal muscle and fascia lata were used as controls. In addition, the thickness, cell density, and total cell count of the cambium layer were measured in 24 explants from the donor sites on the ilium and the upper, middle, and lower proximal tibia. At 6 weeks, histomorphometry and quantitative collagen typing were performed. The periosteal donor sites could be grouped into three categories according to chondrogenic potential: ilium (best), scapula and tibia, and skull (no chondrogenesis). The scapular periosteum was slightly better than that from the tibia. Within the tibia, the upper and middle zones of the proximal region were similar and were slightly better than the lower proximal tibia or the distal tibia. The cellularity of the cambium layer correlated positively with the amount of cartilage as a percentage of the total area. The results of this study indicate that iliac periosteum exhibited the best overall chondrogenic potential in vitro but that periosteum from the traditionally used medial proximal tibia also was excellent. Periosteum from the skull was not chondrogenic. The chondrogenic potential of periosteum varies from bone to bone and within the periosteum from one bone. This variation in chondrogenic potential among donor sites may be due to a difference in the total cell count of the cambium layer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8064482     DOI: 10.1002/jor.1100120408

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  15 in total

Review 1.  Concise review: the periosteum: tapping into a reservoir of clinically useful progenitor cells.

Authors:  Hana Chang; Melissa L Knothe Tate
Journal:  Stem Cells Transl Med       Date:  2012-05-30       Impact factor: 6.940

Review 2.  Novel approaches to bone grafting: porosity, bone morphogenetic proteins, stem cells, and the periosteum.

Authors:  Peter Petrochenko; Roger J Narayan
Journal:  J Long Term Eff Med Implants       Date:  2010

3.  Human periosteum is a source of cells for orthopaedic tissue engineering: a pilot study.

Authors:  Michael D Ball; Ian C Bonzani; Melissa J Bovis; Andrew Williams; Molly M Stevens
Journal:  Clin Orthop Relat Res       Date:  2011-11       Impact factor: 4.176

4.  Pretreatment of periosteum with TGF-beta1 in situ enhances the quality of osteochondral tissue regenerated from transplanted periosteal grafts in adult rabbits.

Authors:  A Olivos-Meza; J S Fitzsimmons; M E Casper; Q Chen; K-N An; T J Ruesink; S W O'Driscoll; G G Reinholz
Journal:  Osteoarthritis Cartilage       Date:  2010-07-13       Impact factor: 6.576

5.  MicroRNA Levels as Prognostic Markers for the Differentiation Potential of Human Mesenchymal Stromal Cell Donors.

Authors:  Nicole Georgi; Hanna Taipaleenmaki; Christian C Raiss; Nathalie Groen; Karolina Janaeczek Portalska; Clemens van Blitterswijk; Jan de Boer; Janine N Post; Andre J van Wijnen; Marcel Karperien
Journal:  Stem Cells Dev       Date:  2015-06-17       Impact factor: 3.272

6.  Histone deacetylase 3 depletion in osteo/chondroprogenitor cells decreases bone density and increases marrow fat.

Authors:  David F Razidlo; Tiffany J Whitney; Michelle E Casper; Meghan E McGee-Lawrence; Bridget A Stensgard; Xiaodong Li; Frank J Secreto; Sarah K Knutson; Scott W Hiebert; Jennifer J Westendorf
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

7.  Arthritic periosteal tissue from joint replacement surgery: a novel, autologous source of stem cells.

Authors:  Hana Chang; Denitsa Docheva; Ulf R Knothe; Melissa L Knothe Tate
Journal:  Stem Cells Transl Med       Date:  2014-01-29       Impact factor: 6.940

8.  Rejuvenation of periosteal chondrogenesis using local growth factor injection.

Authors:  G G Reinholz; J S Fitzsimmons; M E Casper; T J Ruesink; H W Chung; J C Schagemann; S W O'Driscoll
Journal:  Osteoarthritis Cartilage       Date:  2008-11-06       Impact factor: 6.576

9.  The vascularized periosteum flap as novel tissue engineering model for repair of cartilage defects.

Authors:  Leila Harhaus; Jung-Ju Huang; Shu-Wei Kao; Yen-Lin Wu; Gina Alicia Mackert; Bernd Höner; Ming-Huei Cheng; Ulrich Kneser; Chao-Min Cheng
Journal:  J Cell Mol Med       Date:  2015-03-05       Impact factor: 5.310

10.  Overexpressing sonic hedgehog peptide restores periosteal bone formation in a murine bone allograft transplantation model.

Authors:  Chunlan Huang; Minghui Tang; Eric Yehling; Xinping Zhang
Journal:  Mol Ther       Date:  2013-10-03       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.